Table 2.
Peptide masses obtained by MALDI-TOF/MS of in-gel tryptic digests of 22-kDa hGH, 45-kDa hGH, or their reduced and alkylated derivatives
Expected mass of hGH tryptic peptide | Numeric order of tryptic peptide (T)in hGH sequence | Tryptic peptide’s range of residues in hGH | Amino acid sequence of hGH tryptic peptide | Observed mass of 22-kDa hGH tryptic peptide | Observed massa of 22-kDa hGH tryptic peptide | Observed mass of MER-45-kDa hGH tryptic peptide | Observed massa of MER-45-kDa hGH tryptic peptide |
693.39 | T13 | 135–140 | TGQIFK | 693.48 | — | 693.40 | — |
764.43 | T19 | 173–178 | VETFLR | 764.52 | — | — | — |
773.38 | T12 | 128–134 | LEDGSPR | 773.46 | — | — | — |
844.49 | T8 | 71–77 | SNLELLR | 842.61 | 844.58 | 844.50 | 844.51 |
930.54 | T1 | 1–8 | FPTIPLSR | 930.65 | 930.62 | 930.54 | 930.54 |
979.50 | T2 | 9–16 | LFDNAMLR | 979.62 | 979.59 | 979.50 | 979.51 |
995.50 | T2b | 9–16 | LFDNAMLR | 995.61 | 995.59 | 995.50 | 995.50 |
1148.56 | T16 | 159–167 | NYGLLYCFR | 1148.55 | — | 1148.55 | — |
1205.58 | T16c | 159–167 | NYGLLYCFR | — | 1205.69 | — | 1205.61 |
1253.62 | T18–T19d | 169–178 | DMDKVETFLR | 1253.78 | 1253.73 | 1253.60 | 1253.62 |
1269.61 | T18–T19b,d | 169–178 | DMDKVETFLR | — | 1269.73 | 1269.57 | 1269.64 |
1361.67 | T11 | 116–127 | DLEEGIQTLMGR | 1361.87 | 1361.81 | 1361.66 | 1361.70 |
1377.67 | T11b | 116–127 | DLEEGIQTLMGR | 1377.85 | 1377.80 | 1377.63 | 1377.68 |
1489.69 | T15 | 146–158 | FDTNSHNDDALLK | 1489.89 | 1489.83 | 1489.69 | 1489.73 |
2262.13 | T10 | 95–115 | SVFANSLVYGASDSNVYDLLK | 2262.33 | 2262.36 | 2262.96 | 2262.18 |
2342.13 | T4 | 20–38 | LHQLAFDTYQEFEEAYIPK | 2342.37 | — | 2341.98 | 2342.09 |
2673.26 | T6c | 42–64 | YSFLQNPTSLCFSESIPTPSNR | — | — | — | 2673.23 |
2676.25 | T15–T16–T17d | 146–168 | FDTNSHNDDALLKNYGLLYCFRK | — | 2676.40 | — | — |
a Reduced and alkylated protein.
b Oxidized methionine.
c Alkylated peptide.
d Incomplete cleavage.